• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Zydus Lifesciences Limited — Updates, 14-11-2025: Press Release

    14-11-2025 | 01:42 pm

    Zydus received USFDA final approval for Leuprolide Acetate injection, used for advanced prostatic cancer. This drug had annual sales of USD 69 mn in the US market.

    No comments yet. Be the first to comment!

    All announcements from Zydus Lifesciences Limited